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• In adults, the most common locations for CD include the chest (60%), neck (14%), 
abdomen (11%), and axilla (4%); in children, the chest (33%) remains the most 
common site of disease, followed by the abdomen (30%), neck (23%) and axilla 
(7%).6-13 Data are currently inconclusive as to the most common neck level for 
pediatric CD. In our literature analysis, level V was the most common location, 
representing 25% of lesions. 
• All of the evaluated children had unicentric masses. While no multicentric disease was 
found, it is important to note that only 17% (5 of 30) of children in this literature review 
received full body work-ups to rule out this possibility. Therefore, it is difficult to make 
this conclusion definitively.  
• Radiographic imaging is non-specific.4  
• CT was the most common modality used for neck mass work-up in this analysis 
(47%); however, the results argue that CT is no more specific for diagnosing CD than 
any other modality. As such, it is reasonable to conclude that while CD should remain 
on the differential diagnosis for any pediatric neck mass, the imaging modality of 
choice should be whichever modality will evaluate for the etiology highest on the 
differential diagnosis for an individual patient. Additionally, since most of these patients 
will proceed to surgery, pursuing CT or MRI may serve a dual purpose of both 
attempted diagnosis and preoperative planning. Imaging to search for multicentric 
disease should be based on the patient’s symptoms and on clinical suspicion. 
• Definitive treatment of unicentric CD involves surgical excision, with excellent 
prognosis. Lin et al reported no recurrence after 109 months of follow-up in one 
patient, which represents the longest follow-up of pediatric neck CD to our 
knowledge.17 Another study showed a 100% five-year control rate after surgical 
excision of an isolated cervical mass.12 Our analysis supports this data with no 
recurrences seen during a mean follow-up of 30 months. 
 
A 13-year-old female presented to our institution with a tender right-neck mass that 
appeared suddenly. It had been present for six weeks, during which time the mass had 
not changed in size but did cause mild pain with head movement to the right. She had no 
significant previous medical history. Exam revealed a 4 x 6-cm mass deep to the lower 
half of the sternocleidomastoid muscle on the right. It was non-tender to palpation with 
no overlying skin changes. Routine laboratory tests were within normal limits. Titers for 
toxoplasma, cytomegalovirus (CMV), and Bartonella were negative. Epstein–Barr virus 
(EBV) IgG titers were elevated. Chest radiograph was within normal limits. Magnetic 
resonance imaging (MRI) revealed a well-defined, right-sided level III mass measuring 
1.8 x 3.0 x 4.2 cm. It was bright on T2- and intermediately to slightly brighter than muscle 
on T1-weighted imaging (Figure 1). Several small vascular channels were apparent on 
the lesion by  MRI. Several small lymph nodes along the inferior margin of the lesion 
extending down to the thoracic inlet were also noted. An additional 12 x 6 x 9-mm lesion 
was noted in the paraspinal musculature. A decision was made not to pursue this lesion 
given its small size and location, which would be unusual for CD. Fine needle aspiration 
(FNA) revealed atypical lymphoid proliferation. After discussion with the patient and 
family regarding the options, she was taken to the operating room, where a complete 
surgical excision of the mass was performed. Histologically, the nodal mantle zone 
showed concentric rings with an onion-skin appearance. Piercing blood vessels were 
frequently seen in these follicles ("lollipop" feature)  (Figure 2). The interfollicular areas 
showed prominent hyalinized venules. Based on these findings, the postoperative 
histopathological diagnosis was HV-CD. At three months’ follow-up, she was doing well 
with no signs of recurrence.  
Castleman disease (CD) was first described by Benjamin Castleman in 1954.1,2 Since 
that time, CD has become better known in literature as a lymphoproliferative disorder of 
unknown etiology.3-5 Castleman disease can occur anywhere throughout the lymphatic 
system. The most common sites include the mediastinum (60%), neck (14%), abdomen 
(11%), and axilla (4%).6-11 While the underlying etiology is unknown, several hypotheses 
have been suggested. One theory postulates that the disease represents a reaction to a 
chronic viral antigenic stimulation. Some studies cite a role for interleukin-6 (IL-6).8 
Castleman disease is rare in the pediatric population, although exact prevalence rates are 
not known.8,12 In children, CD has a more benign prognosis. It also has a different 
propensity for certain anatomic sites compared to adults, most commonly affecting the 
chest (33%), abdomen (30%), neck (23%), and axilla (7%).12,13 In contrast, the most 
commonly affected sites in adults are the chest (60%), neck (14%), abdomen (11%), and 
axilla (4%).7-11  
To better understand the clinical characteristics of this rare entity in children, in this study, 
we present a case study followed by an extensive literature review of pediatric cervical 
CD.  
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ABSTRACT 
MATERIALS AND METHODS 
Nemours is an internationally recognized children’s health system that owns and operates the Nemours/Alfred I. duPont Hospital for Children in 
Wilmington, DE, along with major pediatric specialty clinics in Delaware, Florida, Pennsylvania, and New Jersey. In October 2012, it opened the 
full-service Nemours Children’s Hospital in Orlando, Florida. To learn more about Nemours, visit www.Nemours.org. 
CASE REPORT 
Objective: To investigate the common features of cervical pediatric Castleman disease (CD). 
Study Design: Case report and literature review of pediatric patients with cervical CD. 
Methods: Online medical journal databases were searched for patients aged 18 years or 
younger. Eighteen published papers were found, comprising 29 cases. One case from our 
institution was also included for a total of 30 patients.  
Results: An asymptomatic mass in level V was the most common presentation. No gender 
differences were noted. Multiple forms of imaging were pursued, and no particular modality 
showed signs specific for CD. All cases were treated with complete surgical excision and 
diagnosed as hyaline-vascular type on histology, except for one case, where histologic type was 
not reported. No reports of multicentric disease, plasma cell, or mixed histology were found. No 
recurrences were reported. 
Conclusions: This poster provides the largest known literature review of pediatric patients with 
cervical CD. In our analysis, there is a higher propensity for level V than previously reported in 
small studies. While CD is rare, it should be considered on the differential for a pediatric neck 
mass, particularly when presenting with an asymptomatic posterior neck mass and equivocal 
work-up. Fortunately, our study suggests that, if diagnosed as CD, the most likely diagnosis is 
hyaline-vascular type for which the long-term prognosis is good. Surgical excision is both 
diagnostic and therapeutic. 
 
Online medical journal databases were used for data collection. “Castleman’s disease” in 
combination with “neck”, “cervical,” and “pediatric”, were keywords used for searching the 
PubMed database. Only patients aged 18 and younger were included for analysis. After 
excluding reports on CD in other locations (ie, non-neck sites), 18 published papers were 
found, comprising 29 total reported cases of pediatric cervical CD (Table 1). The earliest 
case report published was in 1991 and the latest in 2012.5,19 In addition, one patient was 
diagnosed and treated at our institution. This patient was also included and brought our 
final patient count to 30 cases. This study was IRB exempt. All diagnoses of CD were 
based on histopathology. 
DISCUSSION 
CONCLUSIONS 
Cervical pediatric CD is rare. It most commonly presents as an asymptomatic or slowly 
enlarging level V mass. Imaging characteristics are often non-specific and do not aid in 
the diagnosis. Imaging is important in excluding  other diagnoses and to allow for 
preoperative planning. No specific lab abnormality is consistently seen in these patients, 
nor is FNA diagnostic. Excision is ultimately diagnostic and therapeutic, and when 
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Figure 1. Neck magnetic resonance imaging 
of right-neck mass. Axial T2-weighted cut 
shows a hyperintense mass. 
Figure 2. Castleman disease showing 
lymphoid follicle with onion-skinning of the 
mantle zone lymphocytes; 200x. 
Reference Year Age Gender Location/Level Signs/symptoms 
Duration 
(mo) Size (cm) CT Neck MRI Neck U/S Neck CXR CT C/A/P Other Imaging FNA? 
Abnormal 
Labs DDx Treatment Path F/U (mo) Recurrence? 
Lin14 2010 9 M L level V painless neck mass 6 1.5 x 2.0 well-defined neck mass x x x CT C/A- neg x x x excision CD, HV-type 36 none 
Penfold5 1991 11 M L level V ("post neck") enlarging mass x 6mo 132 3.0 x x x nl x x x x excision CD, HV-type x x 
Glazer15 1995 11 F R level V ("post neck") slow growing mass 3 3.2 x 2.5 x 1.6 x 
isointense  w/ muscle, central 
hypodensity, no enhance appearance of large LN x MRI C/A- neg x none x excision CD, HV-type x x 
Koslin16 1985 17 M R neck 
recent growth, no pain, dysphagia, 
dyspnea, hoarseness, fatigue, wt loss 5 3.6 x 3.6 
homogenously enhancing, displaced 
vascular bundle medially x x x x 
Angio- mass w/ 
vasc blush x x 
carotid body chemodectoma, 
vagal neuroma, granulomatous 
d/o, lymphoma excision CD, HV-type x x 
Cakabay4 2009 17 F R level V ("post neck") neck swelling 12 4.0 x 2.0 x 2.5 irregular borders x x x x x x none x excision CD, HV-type ? none 
Salisbury17 1990 5 M L cervical slow growing mass 24 4.0 x 2.5 x 2.5 x x x x x x x x x excision CD, HV-type 11 none 
Patel18 1998 12.5 M 
L level III ("ant tri, level thyroid 
cart") asymptomatic x 3.0 x 2.5 x 1.0 x x 
heterogeneous mass w/ 
hypoechoic central 
portion, central flow x x x x x enlarged, necrotic LN excision CD, HV-type x x 
Bond10 2003 13 F Level I (midline submental) unsightly neck mass 24 2.0 x 
intermediate T1 signal, elevated T2 
signal x x x x x x x excision CD, HV-type x x 
Tuerlinckx13 1997 14 M R lateral neck asymptomatic 24 4.2 x 3.8 x 1.9 
enhancing mass.  Homogeneous, 
dense. x x x CT C/A- neg x x none x excision CD, HV-type 8 none 
Tuerlinckx13 1997 7 M L cervical increasing mass size 2 5.0 x 4.5 x 2.0 x 
homogeneous, isointense T1 signal, 
hyperintense T2 signal, moderate 
enhancement x nl 
BM aspiration- neg 
Abd- neg x 
?? Reference 
values not 
given Hodgkins excision CD, HV-type 5 none 
Zhong6 2010 14 F R neck none 12 2.0 x 2.0  x x x x x x x none x excision CD, HV-type 34 none 
Zhong6 2010 13 F R neck none 3 2.0 x 3.0 x 
uniform signal T1, nonuniform signal 
T2 
oval shaped w/ clear 
boundary, uniform low-
level echo, intact 
envelope x x x x none x excision CD, HV-type 60 none 
Souza11 2008 12 F L Level III   none 6 
3.4 x 0.9 (max..4 
LN in total) no description x 
performed- no 
characteristics 






lymphadenitis excision CD, HV-type 36 none 
Souza11 2008 16 F R Level II/III slow growing mass 96 10.0 x x 
performed- no 
characteristics 








, high ESR, 
rheumatoid 
factor pos 
cystic hygroma removed from 
same area 4 years prior excision CD, HV-type 34 none 
Souza11 2008 11 F R neck increasing mass size 5 3.6 x x 
elliptical hypoecogenic 
nodule, well-defined 
smooth  limits x x x 
many small lymphcytes 
and lymph-histiocytic 
aggregates  none 
lymphoid hyperplasia, 
lymphangioma excision CD, HV-type 25 none 
Chen19 2012 13 F L level II x 24 4.0 x 4.0 performed- no characteristics given x x x x x x x x regional dissection CD, HV-type 62 x 
Chen19 2012 13 M R level II  x 12 4.0 x 3.0 performed- no characteristics given x x x x x x x x excision CD, HV-type 109 x 
Chen19 2012 13 F L level II x 12 3.5 x 2.5 performed- no characteristics given x x x x x x x x excision CD, HV-type 83 x 
Chen19 2012 13 M L level Ib x 12 2.5 x 2.5 performed- no characteristics given x x x x x x x x level Ib dissection CD, HV-type 16 x 
Chen20 2006 12 F Level I* asymptomatic 6 5.0 x 4.0 x 2.5 x x x x x x x x x excision CD, HV-type x none 
Zhong12 2004 6 F R neck asymptomatic mass 2 2.5 x 3.0 x 2.0 homogeneous mass x x nl x MRA x none x excision CD, HV-type 6 none 
Song21 2006 7 M Level IV* x x 2.0 x 1.0 
isodense to soft tissue, well 
circumscribed x x x x x 
? Inconclusive (doesn’t 
say which pts got FNA) none x excision CD, HV-type 10 none 
Song21 2006 11 M Level II* x x 2.0 x 1.0 
isodense to soft tissue, well 
circumscribed x x x x x 
? Inconclusive (doesn’t 
say which pts got FNA) none x excision CD, HV-type 11 none 
Song21 2006 17 F Level III* x x 3.0 x 3.0 
isodense to soft tissue, well 
circumscribed x x x x x 
? Inconclusive (doesn’t 
say which pts got FNA) none x excision CD, HV-type 13 none 
Lin22 2010 16 F Level II/III* asymptomatic 2 4.2 x 3.5 x 2.0 x x x x x x x x x excision CD, HV-type x none 
Lin22 2010 9 M Level V* asymptomatic 6 2.0 x 2.0  x x x x x x x x x excision CD, HV-type x none 
Rao23 2008 5 M L Level V painless neck mass 11 1.5 x 1.5 x x 
performed- no 
characteristics 
discussed nl x abd u/s x none reactive lymphadenopathy excision CD, type not mentioned 6 none 
Chen24 2007 9 F L neck x 24 x x x x x x x x x x excision CD, HV-type 39 none 
Tan25 2003 12 M L level III non-tender, mobile mass 3 4.0 
ovoid enhancing node, low-attenuation 
stellate band in the center of mass X x x x x x x x x CD, HV-type x x 
Rabinowitz  
(not yet 
published) 2012 13 F R Level III painful neck mass 4 1.8 x 3.0 x 4.2 x 
bright T2, int to slightly bright to 
muscle on T1, slight uniform 
enhancement, hyperemic nl x x 
atypical lymphoid 
proliferation high IgG EBV 
lymphoma, fibroma, 
fibrosarcoma, neurofibroma excision CD, HV-type 6 none 
x, unknown or not reported; *, unknown side; CD HV, Castleman disease hyaline-vascular type; abd,  abdomen; u/s, ultrasound; CXR, chest x-ray; CT, computed tomography; MRI, magnetic resonance imaging; f/u, follow-up; C/A/P, CT 
chest/abdomen/pelvis; FNA, fine needle aspiration; DDx, differential diagnosis; mo, months 
Table 1. Castleman data 
